Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Co-Diagnostics, Inc. (CODX)Business Wire • 08/17/22
EQUITY ALERT: Rosen Law Firm Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CODXBusiness Wire • 08/16/22
Co-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/11/22
CoDiagnostics, Inc. (CODX) Reports Q2 Loss, Lags Revenue EstimatesZacks Investment Research • 08/11/22
Co-Diagnostics ends 2Q with $96M in cash, expands infectious disease testing menu to include monkeypoxProactive Investors • 08/11/22
CO-DIAGNOSTICS, INC. ANNOUNCES FIRST QUARTER 2022 EARNINGS RELEASE DATE AND WEBCASTPRNewsWire • 08/02/22
Co-Diagnostics, Inc. to Participate in Yale University SalivaDirect™ Conference Held July 28-29 in ChicagoPRNewsWire • 07/27/22
CoDiagnostics, Inc. (CODX) Surges 5.8%: Is This an Indication of Further Gains?Zacks Investment Research • 07/26/22
Co-Diagnostics set to expand OEM deal with Bio Molecular Systems at AACC expoProactive Investors • 07/26/22
Co-Diagnostics, Inc. to Announce Expansion of OEM Agreement with Bio Molecular Systems at AACCPRNewsWire • 07/26/22
Co-Diagnostics ships monkeypox virus tests to international distributor to fight multi-country outbreakProactive Investors • 07/11/22
Co-Diagnostics, Inc. to Present at 29th International Biodetection Technologies Virtual ConferencePRNewsWire • 06/28/22
CoDiagnostics, Inc. (CODX) Surges 5.6%: Is This an Indication of Further Gains?Zacks Investment Research • 06/24/22
Co-Diagnostics, Inc. to Host Booth at MEDEXPO Africa 2022 in Nairobi, Kenya on June 9-11PRNewsWire • 06/09/22